AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Proquin XR indicated for UTI.(PRODUCTS)

OB GYN News

| July 01, 2005 | COPYRIGHT 2005 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Proquin XR (ciprofloxacin hydrochloride) extended-release tablets (500 mg) is indicated for the treatment of uncomplicated urinary tract infections (acute ...

Related articles from newspapers, magazines, journals, and more
Proquin XR indicated for UTI.(PRODUCTS)(urinary tract infections )(Brief...
Magazine article from: Internal Medicine News August 1, 2005 700+ words
Proquin XR (ciprofloxacin hydrochloride) extended-release tablets (500 mg) are indicated for treatment of uncomplicated urinary tract...
Depomed Receives FDA Approval of Proquin XR for Uncomplicated Urinary Tract...
Press release article from: Business Wire May 20, 2005 700+ words
...uncomplicated urinary tract infections (UTIs). Proquin XR is the first version of ciprofloxacin...Carolina Urologic Research Center. "Proquin XR is a new, once-daily version of ciprofloxacin...within approximately two hours, while Proquin XR is designed to gradually release the...
DEPOMED'S PROQUIN XR WINS FDA APPROVAL AS TREATMENT FOR UTIS.
Magazine article from: BIOWORLD Today Lorenzo, Aaron May 23, 2005 700+ words
...percent on news that the FDA approved Proquin XR, a once-daily, extended-release...uncomplicated urinary tract infections (UTIs), Proquin XR's efficacy is being touted by Depomed...trial of 1,037 patients showed that Proquin XR eradicated 93.4 percent of the bacteria...
Depomed's Proquin XR Wins FDA Approval As Treatment For UTIs.
Magazine article from: BIOWORLD Today November 3, 2009 700+ words
...percent on news that the FDA approved Proquin XR, a once-daily, extended-release...uncomplicated urinary tract infections (UTIs), Proquin XR's efficacy is being touted by Depomed...trial of 1,037 patients showed that Proquin XR eradicated 93.4 percent of the bacteria...
DEPOMED/MADAUS SIGN PACT FOR PROQUIN XR IN EUROPE.
Newspaper article from: Worldwide Biotech January 1, 2006 700+ words
...to Madaus for the commercialization of ProQuin XR in Europe and has agreed to supply Madaus with commercial quantities of ProQuin XR tablets in bulk form. In return, Madaus will pay Depomed for ProQuin XR tablets at a pre-specified percent...
Depomed and Madaus S.r.l. Enter into Agreement for ProQuin XR in Europe.
Press release article from: Business Wire November 29, 2005 700+ words
...to Madaus for the commercialization of ProQuin XR in Europe and has agreed to supply Madaus with commercial quantities of ProQuin XR tablets in bulk form. In return, Madaus will pay Depomed for ProQuin XR tablets at a pre-specified percent...
Esprit's ProQuin XR 'a step forward'.(Esprit Pharma launches new urinary...
Magazine article from: Chain Drug Review April 10, 2006 700+ words
...BRUNSWICK, N.J. -- Esprit Pharma's ProQuin XR, a new prolonged-release quino-lone...of patients treated in a trial with ProQuin XR did not experience either symptom. Billed...formulations. Once-daily 500-mg ProQuin XR is not a generic drug. Because of its...
Depomed Submits New Drug Application to FDA for Proquin XR -- Ciprofloxacin GR.
Press release article from: Business Wire July 20, 2004 700+ words
...objective of submitting an application for Proquin XR," said John W. Fara, Ph.D., chairman...markets. Upon potential approval of Proquin XR, we look forward to providing patients...treatment with Depomed's once-daily Proquin XR compared to a three-day course of treatment...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA